HEALTH● LOWOct 5 · Oct 5, 2026, 11:44 AM
FDA approves additional U.S. manufacturing capacity for Simlandi, Alvotech’s biosimilar to Humira
Seeking Alpha Tech · north america
The FDA has approved expanded manufacturing capacity in the U.S. for Simlandi, Alvotech's biosimilar to Humira. This approval aims to increase the availability of the drug.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH42m agoA tooth grew in a teenager's eye and doctors removed it with surgery: the case that amazed world medicineClarínHEALTH45m agoFG releases ₦40.7 billion for primary healthcare, expands coverage to 13,000 facilitiesPremium TimesHEALTH52m agoAmericans with disabilities worried over plan to slash national health surveyThe Independent WorldHEALTH56m agoWell-wishers rally behind Pope Leo XIV as he recovers from cancer surgeryAfricanews [en]